Research Article

CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques

Volume: 35 Number: 2 May 30, 2022
  • Muhammed Akif Denız *
  • Caglayan Cakır
  • Fatih Kılınc
  • Osman Kurt
  • Zelal Tas Denız
EN

CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques

Abstract

Objective: We aimed to evaluate the diagnostic accuracy and complication rates of computed tomography (CT)-guided core needle biopsy and fine needle aspiration biopsy (FNAB). Materials and

Methods: Patients who underwent CT-guided lung mass biopsy were included. The patients were evaluated in terms of age, gender, lesion diameter, lesion localization, depth of the mass, type of biopsy procedure (core needle biopsies and FNAB).

Results: The accuracy rate of FNAB in diagnostic material was found to be 100% in terms of benign, malignant and all lesions. The specificity and sensitivity of FNAB was found to be 100%. The diagnostic accuracy rate of core needle biopsy was found to be 70% in benign lesions, 100% in malignant lesions. The specificity of core needle biopsy was 90% and sensitivity 100%. There was no statistically significant difference between the two biopsy techniques in terms of complications.

Conclusion: In conclusion, we found that the diagnostic rates of FNAB and core needle biopsy were close in malignant lesions, the diagnostic rate of core needle biopsy was higher in benign lesions, and there was no difference in terms of complications in both biopsy techniques.

Keywords

References

  1. [1] Richardson CM, Pointon KS, Manhire AR, Macfarlane JT. Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies. Br J Radiol 2002;75: 731-5. doi:10.1259/ bjr.75.897.750731
  2. [2] Brioulet J, David A, Sagan C, Cellerin L, Frampas E, Morla O. Percutaneous CT-guided lung biopsy for the diagnosis of persistent pulmonary consolidation. Diagn Interv Imaging 2020;101:727-32, doi:10.1016/j.diii.2020.07.007
  3. [3] Yeow KM, See LC, Lui KW, et al. Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions. J Vasc Intervent Radiol 2001; 12: 1305-12. doi: 10.1016/s1051-0443(07)61556-5
  4. [4] Çakır Ö, Çam İ, Koç U, Çiftçi E. Evaluation of major complications associated with percutaneous CT-guided biopsy of lung nodules below 3 cm. Turk J Med Sci 2020;50: 369-74. doi:10.3906/sag-1908-73
  5. [5] Manhire A, Chairman CM, Clelland C, et al. Guidelines for radiologically guided lung biopsy. Thorax 2003;58:920-36. doi: 10.1136/thorax.58.11.920
  6. [6] Layfield LJ, Coogan A, Johnston WW, et al Transthoracic fine needle aspiration biopsy: sensitivity in relation to guidance technique and lesion size and location. Acta Cytol 1996; 40: 687-90. doi: 10.1159/000333940.
  7. [7] Larscheid RC, Thorpe PE, Scott WJ. Percutaneous transthoracic needle aspiration biopsy: a comprehensive review of its currentrole in the diagnosis and treatment of lung tumors. Chest 1998; 114:704-09. doi: 10.1378/chest.114.3.704.
  8. [8] Yaffe D, Koslow M, Haskiya H, Shitrit D. A novel technique for CT-guided transthoracic biopsy of lung lesions: improved biopsy accuracy and safety. Eur Radiol 2015;25:3354-60. doi: 10.1007/s00330.015.3750-z.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Muhammed Akif Denız * This is me
0000-0002-9586-2425
Türkiye

Caglayan Cakır This is me
0000-0001-8030-6795
Türkiye

Fatih Kılınc This is me
0000-0002-7224-7737
Türkiye

Zelal Tas Denız This is me
0000-0001-5986-5293
Türkiye

Publication Date

May 30, 2022

Submission Date

November 27, 2021

Acceptance Date

-

Published in Issue

Year 2022 Volume: 35 Number: 2

APA
Denız, M. A., Cakır, C., Kılınc, F., Kurt, O., & Tas Denız, Z. (2022). CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques. Marmara Medical Journal, 35(2), 219-224. https://doi.org/10.5472/marumj.1120552
AMA
1.Denız MA, Cakır C, Kılınc F, Kurt O, Tas Denız Z. CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques. Marmara Med J. 2022;35(2):219-224. doi:10.5472/marumj.1120552
Chicago
Denız, Muhammed Akif, Caglayan Cakır, Fatih Kılınc, Osman Kurt, and Zelal Tas Denız. 2022. “CT-Guided Lung Biopsy: Diagnostic Accuracy and Complication Rates of Biopsy Techniques”. Marmara Medical Journal 35 (2): 219-24. https://doi.org/10.5472/marumj.1120552.
EndNote
Denız MA, Cakır C, Kılınc F, Kurt O, Tas Denız Z (May 1, 2022) CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques. Marmara Medical Journal 35 2 219–224.
IEEE
[1]M. A. Denız, C. Cakır, F. Kılınc, O. Kurt, and Z. Tas Denız, “CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques”, Marmara Med J, vol. 35, no. 2, pp. 219–224, May 2022, doi: 10.5472/marumj.1120552.
ISNAD
Denız, Muhammed Akif - Cakır, Caglayan - Kılınc, Fatih - Kurt, Osman - Tas Denız, Zelal. “CT-Guided Lung Biopsy: Diagnostic Accuracy and Complication Rates of Biopsy Techniques”. Marmara Medical Journal 35/2 (May 1, 2022): 219-224. https://doi.org/10.5472/marumj.1120552.
JAMA
1.Denız MA, Cakır C, Kılınc F, Kurt O, Tas Denız Z. CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques. Marmara Med J. 2022;35:219–224.
MLA
Denız, Muhammed Akif, et al. “CT-Guided Lung Biopsy: Diagnostic Accuracy and Complication Rates of Biopsy Techniques”. Marmara Medical Journal, vol. 35, no. 2, May 2022, pp. 219-24, doi:10.5472/marumj.1120552.
Vancouver
1.Muhammed Akif Denız, Caglayan Cakır, Fatih Kılınc, Osman Kurt, Zelal Tas Denız. CT-guided lung biopsy: diagnostic accuracy and complication rates of biopsy techniques. Marmara Med J. 2022 May 1;35(2):219-24. doi:10.5472/marumj.1120552

Cited By